People suffering from cancer spreading to the brain can expect to have a prolonged life and enjoy a better quality of life when treated with a combination of radiation techniques, according to research conducted, in part, at the James P. Wilmot Cancer Center at the University of Rochester Medical Center.
Michael C. [...]
May 31, 2010 | Posted in
Steroids Blog |
Read More »
According to a study on the incidence of liver cancer, high levels of the immunosuppressant cyclosporine favor tumor recurrence. This study was also able to identify blood levels of the drug that should not exceed and indicated that low levels of cyclosporine have no effect on the rejection rates.
Results of the [...]
May 31, 2010 | Posted in
Steroids Blog |
Read More »
A potential new treatment for the death of bone tissue or osteonecrosis in people who are treated with steroids for many common medical conditions was recently found by researchers at Mount Sinai School of Medicine.
Presently, no treatment options are available for people afflicted with this debilitating disease.
From Medicalnewstoday.com:
Glucocorticoids are a class [...]
May 30, 2010 | Posted in
Steroids Blog |
Read More »
As per a report by researchers in an issue of The New England Journal of Medicine, almost half of the patient afflicted with a debilitating form of inflammatory bowel noticed disappearance of their disease symptoms within a period of six weeks after using a medication that was usually reserved for patients [...]
May 29, 2010 | Posted in
Steroids Blog |
Read More »
A molecule which is part of a family of ‘fountain-of-youth’ steroids can trigger a protective effect for preventing heart diseases, as per researchers at the University of Leeds.
The name ‘fountain-of-youth’ steroid is provided as these steroids offer the apparent ability to improve energy, vision, and memory.
The molecule, pregnenolone sulphate, in these steroids can [...]
May 28, 2010 | Posted in
Steroids Blog |
Read More »
Infants born at 22 to 24 weeks’ gestation at one academic medical center in 2001 to 2003 were found to be at an increased risk than infants who were born between 1993 and 1995 and benefited from less of life-sustaining interventions and still enjoyed a better survival rate.
The finding was reported in [...]
May 28, 2010 | Posted in
Steroids Blog |
Read More »
Treatment of severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy, is possible with a drug previously approved for the treatment of non-Hodgkin’s B cell lymphoma and rheumatoid arthritis.
Rituxan, the drug, was identified by researchers in treating severe ANCA-associated vasculitis. The news was presented at an annual meeting [...]
May 27, 2010 | Posted in
Steroids Blog |
Read More »
A protein which is considered to stimulate blood vessel growth was recently identified to be responsible for cell overgrowth in the development of polyps that characterize one of the most severe sinusitis forms.
The finding was disclosed by researchers from John Hopkins and is considered to have implications for development of novel therapies [...]
May 27, 2010 | Posted in
Steroids Blog |
Read More »
A complication of diabetes that may result in loss of vision and blindness, diabetic retinopathy, can be effectively treated with triamcinolone.
Triamcinolone, the corticosteroids, can slowdown the disease progression after it is directly injected into the human eye, as per a report in the December issue of Archives of Ophthalmology, one of [...]
May 26, 2010 | Posted in
Steroids Blog |
Read More »
An important genetic cause of a lethal kidney complication was identified by researchers from Children’s Hospital Boston and Brigham and Women’s Hospital. This disease is the second leading cause of kidney failure in children, as per The NephCure Foundation.
The study was published online by Nature Genetics study’s coauthors were Johannes Schlöndorff [...]
May 26, 2010 | Posted in
Steroids Blog |
Read More »